Ceiba pentandra ethyl acetate extract improves doxorubicin antitumor outcomes against chemically induced liver cancer in rat model: a study supported by UHPLC-Q-TOF-MS/MS identification of the bioactive phytomolecules

• Egile Nagusiak: Mohamed A. A. Orabi (Egilea), Mohamed E. Abouelela (Egilea), Faten M. M. Darwish (Egilea), Mohamed S. A. Abdelkader (Egilea), Bakheet E. M. Elsadek (Egilea), Ahmed Abdullah Al Awadh (Egilea), Mohammed Merae Alshahrani (Egilea), Abdulaziz Hassan Alhasaniah (Egilea), Nayef Aldabaan (Egilea), Reda A. Abdelhamid (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Hepatocellular carcinoma (HCC) is a prevalent cancer worldwide. Late-stage detection, ineffective treatments, and tumor recurrence contribute to the low survival rate of the HCC. Conventional chemotherapeutic drugs, like doxorubicin (DOX), are associated with severe side effects, limited effectivene...